How big is the hydrocephalus market today, and what are its future growth expectations?
The hydrocephalus market size has grown steadily in recent years. It will grow from $3.54 billion in 2024 to $3.69 billion in 2025 at a compound annual growth rate (CAGR) of 4.3%. The growth in the historic period can be attributed to neurological disorders awareness, pediatric healthcare advances, increased incidence of traumatic brain injuries, improved access to healthcare, research and development initiatives.
The hydrocephalus market size is expected to see strong growth in the next few years. It will grow to $4.66 billion in 2029 at a compound annual growth rate (CAGR) of 6.0%. The growth in the forecast period can be attributed to neuroendoscopy advancements, growing geriatric population, regulatory support for medical devices, rise in traumatic brain injuries, global health initiatives. Major trends in the forecast period include increased focus on pediatric neurology, technological innovations in shunt systems, advancements in medical technology, advancements in surgical techniques, innovation in shunt technologies.
Get Your Free Sample of The Global Hydrocephalus Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6259&type=smp
How has the hydrocephalus market evolved, and what factors have shaped its growth?
The increased prevalence of hydrocephalus is significantly contributing to the growth of the hydrocephalus market. Hydrocephalus is a medical condition in which the cerebrospinal fluid (CSF) starts accumulating in the cavities of brain structures, resulting in a variety of cognitive abnormalities. The increasing incidences of hydrocephalus are increasing the demand for hydrocephalus treatment devices to treat patients. For instance, in August 2022, according to the Hydrocephalus Association, a US-based private non-profit organization, hydrocephalus has affected around 1 million Americans, with 1 in 770 infants being diagnosed with the condition. Additionally, approximately 700,000 seniors in the U.S. are living with normal pressure hydrocephalus (NPH). Therefore, the increased prevalence of hydrocephalus is expected to propel the growth of the hydrocephalus market.
What are the major segments of the hydrocephalus market?
The hydrocephalus market covered in this report is segmented –
1) By Type: Congenital Hydrocephalus, Acquired Hydrocephalus, Normal-Pressure Hydrocephalus, Ex-Vacuo Hydrocephalus
2) By Age Group: Pediatric, Adult
3) By Diagnostics: MRI, CT Scan, Head Ultrasound, Other Diagnostics
4) By End User: Hospitals, Diagnostic Centers, Academic Institutions, Research Organizations
Subsegments:
1) By Congenital Hydrocephalus: Associated With Genetic Disorders, Associated With Neural Tube Defects
2) By Acquired Hydrocephalus: Post-Traumatic Hydrocephalus, Hydrocephalus Due To Tumors, Hydrocephalus Following Infection
3) By Normal-Pressure Hydrocephalus (NPH): Idiopathic Normal-Pressure Hydrocephalus, Secondary Normal-Pressure Hydrocephalus
4) By Ex-Vacuo Hydrocephalus: Hydrocephalus Related To Brain Atrophy, Hydrocephalus Following Stroke Or Injury
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/hydrocephalus-global-market-report
Which companies dominate the hydrocephalus market?
Major companies operating in the hydrocephalus market include Johnson & Johnson Corporation, Thermo Fisher Scientific, Medtronic plc, MIZUHO Co. Ltd., B. Braun Melsungen AG, Helios Hospital, Agilent Technologies Inc., Texas Children’s Hospital, Boston Children’s Hospital, Karl Storz Se And Co. Kg, Integra LifeSciences Corporation, Children’s National Hospital, Natus Medical Incorporated, Aesculap Inc., HLL Lifecare Limited, Sophysa SA, Anadolu Medical Center, Christoph Miethke GmbH & Co. KG, Alcyone Therapeutics Inc., Moller Medical GmbH, Spiegelberg GmbH & Co. KG, G. SURGIWEAR LTD., Tokibo Co. Ltd., HpBio Proteses Inc., Desu Medical, Dispomedica GmbH, Kaneka Medix Corporation, Delta Surgical Limited
How will evolving trends contribute to the growth of the hydrocephalus market?
Major companies operating in the hydrocephalus market are innovating advanced products, such as endovascularly implantable cerebrospinal fluid (CSF) shunts, to improve the management of hydrocephalus by providing minimally invasive solutions to regulate CSF flow and relieve intracranial pressure. An endovascularly implantable cerebrospinal fluid (CSF) shunt is a type of shunt system that is placed within blood vessels (endovascularly) to manage hydrocephalus, a condition characterized by an excess buildup of CSF in the brain. For instance, in August 2024, CereVasc Inc. a US-based clinical-stage medical device company received approval from the Food and Drug Administration (FDA), a US-based federal agency for protecting the public health of eShunt System. eShunt System is a medical device designed for treating Normal Pressure Hydrocephalus (NPH). The system includes an endovascularly implantable cerebrospinal fluid (CSF) shunt that aims to bypass the need for invasive surgery and general anesthesia. The implantation of the eShunt will be performed under local anesthesia using a minimally invasive femoral venous approach, conducted in an angiography suite which is a specialized medical facility.
What are the key regional dynamics of the hydrocephalus market, and which region leads in market share?
The countries covered in the hydrocephalus market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
What Does The Hydrocephalus Market Report 2025 Offer?
The hydrocephalus market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Hydrocephalus is a medical condition in which the cerebrospinal fluid (CSF) that commonly passes through the spaces of the brain and spinal column in normal circumstances starts accumulating in the cavities of brain structures, resulting in a variety of cognitive abnormalities.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6259
About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
